BMJ, doi: 10.1136/bmj.39553.670231.25, (Published 14 May 2008)

Research

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories

¹ Pharmionic Research Center, Rue des Cyclistes Frontière 24, 4600 Visé, Belgium, ² University of Liège, Department of Biostatistics and Medical Informatics, Liège, Belgium, ³ Novartis Pharma, Basel, Switzerland, ⁴ University of California at San Francisco, Center for Drug Development Science, San Francisco, USA, ⁵ University Hospital of Lausanne, Division of Nephrology and Hypertension Consultation, Lausanne, Switzerland

Objective To describe characteristics of dosing history in patients prescribed a once a day antihypertensive medication.

Design Longitudinal database study.

Setting Clinical studies archived in database for 1989-2006.

Participants Patients who participated in the studies whose dosing histories were available through electronic monitoring.

Main outcome measures Persistence with prescribed antihypertensive treatment and execution of their once a day drug dosing regimens.

Results The database contained dosing histories of 4783 patients with hypertension. The data came from 21 phase IV clinical studies, with lengths ranging from 30 to 330 days and involving 43 different antihypertensive drugs, including angiotensin II receptor blockers (n=2088), calcium channel blockers (n=937), angiotensin converting enzyme inhibitors (n=665), β blockers (n=195), and diuretics (n=155). About half of the patients who were prescribed an antihypertensive drug had stopped taking it within one year. On any day, patients who were still engaged with the drug dosing regimen omitted about 10% of the scheduled doses: 42% of these omissions were of a single day’s dose, whereas 43% were part of a sequence of several days (three or more days—that is, drug "holidays"). Almost half of the patients had at least one drug holiday a year. The likelihood that a patient would discontinue treatment early was inversely related to the quality of his or her daily execution of the dosing regimen.

Conclusions Early discontinuation of treatment and suboptimal daily execution of the prescribed regimens are the most common facets of poor adherence with once a day antihypertensive drug treatments. The shortfalls in drug exposure that these dosing errors create might be a common cause of low rates of blood pressure control and high variability in responses to prescribed antihypertensive drugs.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Will screening individuals at high risk of cardiovascular events deliver large benefits? No

Simon Capewell
BMJ 2008 337: a1395. [Extract] [Full Text]

Responding to disasters

Fiona Godlee
BMJ 2008 336: 0. [Extract] [Full Text]

Daily regimen and compliance with treatment

Bernard S Bloom
BMJ 2001 323: 647. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Ho, P. M., Bryson, C. L., Rumsfeld, J. S. (2009). Medication Adherence: Its Importance in Cardiovascular Outcomes. Circulation 119: 3028-3035 [Abstract] [Full text]  
• Farmer, A. (2008). Taking tablets for chronic illness: where next?. Chronic Illness 4: 235-238  
• Sarafidis, P. A., Bakris, G. L. (2008). Resistant Hypertension An Overview of Evaluation and Treatment.. J Am Coll Cardiol 52: 1749-1757 [Abstract] [Full text]  
• Capewell, S. (2008). Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ 337: a1395-a1395 [Full text]  
• (2008). Poor Adherence to Once-Daily Antihypertensive Drugs Is Common. JWatch General 2008: 3-3 [Full text]  

Rapid Responses:

Read all Rapid Responses

What is the patient's lifestyle like?

Eiichiro Sando
bmj.com, 19 May 2008 [Full text]

Re: What is the patient's lifestyle like?

Bernard Vrijens, et al.
bmj.com, 28 May 2008 [Full text]

Online poll

Find out more>>